BfArM
- Local brand name: Exdensur
- Status: approved
Exdensur (DEPEMOKIMAB) regulatory status in Germany.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. BfArM has authorised it.
Glaxosmithkline Llc is the originator. The local marketing authorisation holder may differ — check the official source linked above.